Literature DB >> 30363838

Salvage liver transplant for hepatocellular carcinoma: rescues and benefits.

Shusen Zheng1,2, Qinfen Xie2, Jinkun Cheng3.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China, primary liver transplantation (PLT) and hepatic resection are thought to be the prime and more reasonable treatment. But due to the situation of donor shortage and a higher risk of tumor recurrence, salvage liver transplantation (SLT) is gradually being applied to the patients with HCC, and is confirmed as an effective and feasible treatment for patients. However, the indications and transplantation criteria for SLT still remain controversial. This article reviews the benefits and controversies of SLT and provides an effective reference for the clinical practice.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); primary liver transplantation (PLT); salvage liver transplantation (SLT); transplantation criteria

Year:  2018        PMID： 30363838      PMCID： PMC6182042          DOI： 10.21037/tgh.2018.09.06

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


  36 in total

1.  High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

Authors:  Margarita Sala; Josep Fuster; Josep M Llovet; Miquel Navasa; Manel Solé; María Varela; Fernando Pons; Antoni Rimola; Juan Carlos García-Valdecasas; Concepció Brú; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

2.  Living donor liver transplantation for recurrent hepatocellular carcinoma after liver resection.

Authors:  Toshimi Kaido; Akira Mori; Yasuhiro Ogura; Koichiro Hata; Atsushi Yoshizawa; Taku Iida; Shintaro Yagi; Shinji Uemoto
Journal:  Surgery       Date:  2011-09-22       Impact factor: 3.982

3.  Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.

Authors:  Carlos Margarit; Alfredo Escartín; Lluis Castells; Víctor Vargas; Elena Allende; Itxarone Bilbao
Journal:  Liver Transpl       Date:  2005-10       Impact factor: 5.799

4.  Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.

Authors:  J I Moon; C H D Kwon; J W Joh; G S Choi; G O Jung; J M Kim; M Shin; S J Choi; S J Kim; S-K Lee
Journal:  Transplant Proc       Date:  2012-03       Impact factor: 1.066

5.  Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.

Authors:  Gonzalo Sapisochin; Itxarone Bilbao; Joaquin Balsells; Cristina Dopazo; Mireia Caralt; Jose Luis Lázaro; Luis Castells; Helena Allende; Ramón Charco
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  Salvage living-donor liver transplantation to previously hepatectomized hepatocellular carcinoma patients: is it a reasonable strategy?

Authors:  Sung-Gyu Lee
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2013-02

8.  Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure?

Authors:  Luciano De Carlis; Stefano Di Sandro; Alessandro Giacomoni; Iacopo Mangoni; Andrea Lauterio; Plamen Mihaylov; Caterina Cusumano; Antonio Rampoldi
Journal:  J Clin Gastroenterol       Date:  2013-04       Impact factor: 3.062

9.  Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma.

Authors:  Tomoyuki Abe; Hirotaka Tashiro; Yoshifumi Teraoka; Minoru Hattori; Naoki Tanimine; Shintaro Kuroda; Hiroyuki Tahara; Masahiro Ohira; Yuka Tanaka; Tsuyoshi Kobayashi; Kentaro Ide; Kohei Ishiyama; Hideki Ohdan
Journal:  Dig Surg       Date:  2015-11-10       Impact factor: 2.588

10.  Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: retrospective study of the Milan and Hangzhou criteria.

Authors:  Zhenhua Hu; Jie Zhou; Zhiwei Li; Jie Xiang; Ze Qian; Jian Wu; Min Zhang; Shusen Zheng
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240
View more
  4 in total

1.  A Hypoxia-Sensitive Drug Delivery System Constructed by Nitroimidazole and its Application in the Treatment of Hepatocellular Carcinoma.

Authors:  Tingting Meng; Yinghong Li; Ying Tian; Mingxing Ma; Kequan Shi; Xuwei Shang; Hong Yuan; Fuqiang Hu
Journal:  AAPS PharmSciTech       Date:  2022-06-16       Impact factor: 3.246

2.  Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma.

Authors:  Huiying Gu; Jing Li; Nan You; Ke Wu; Zheng Wang; Liang Wang; Yinan Zhu; Qinqin Liu; Xuehui Peng; Lu Zheng
Journal:  Ann Transl Med       Date:  2020-12

3.  Is partial hepatectomy a curable treatment option for hepatocellular carcinoma accompanied by cirrhosis? A meta-analysis and cure model analysis.

Authors:  Byungje Bae; Keera Kang; Sung Kyu Song; Chul-Woon Chung; Yongkeun Park
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-02-28

Review 4.  Salvage versus Primary Liver Transplantation for Hepatocellular Carcinoma: A Twenty-Year Experience Meta-Analysis.

Authors:  Gian Piero Guerrini; Giuseppe Esposito; Tiziana Olivieri; Paolo Magistri; Roberto Ballarin; Stefano Di Sandro; Fabrizio Di Benedetto
Journal:  Cancers (Basel)       Date:  2022-07-16       Impact factor: 6.575
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.